# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-25-007103
Filing Date
2025-02-18
Accepted
2025-02-18 09:00:22
Documents
8
Period of Report
2025-02-18

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | formdef14a.htm | DEF 14A | 555691
2 |  | formpre14a_001.jpg | GRAPHIC | 28967
3 |  | formpre14a_002.jpg | GRAPHIC | 550663
4 |  | formpre14a_003.jpg | GRAPHIC | 361446
5 |  | proxy_001.jpg | GRAPHIC | 401822
6 |  | proxy_002.jpg | GRAPHIC | 317154
7 |  | proxy_003.jpg | GRAPHIC | 401822
8 |  | proxy_004.jpg | GRAPHIC | 235802
| Complete submission text file | 0001493152-25-007103.txt |  | 3721137

Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Filer) CIK: 0001938046 (see all company filings)

EIN.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41615 | Film No.: 25632934
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 03 Life Sciences)